| Primary |
| Attention Deficit/hyperactivity Disorder |
44.7% |
| Product Used For Unknown Indication |
11.3% |
| Depression |
5.7% |
| Narcolepsy |
5.7% |
| Pain |
5.7% |
| Asthma |
3.1% |
| Major Depression |
3.1% |
| Anxiety |
2.5% |
| Insomnia |
2.5% |
| Abnormal Behaviour |
1.9% |
| Fatigue |
1.9% |
| Psychomotor Hyperactivity |
1.9% |
| Aggression |
1.3% |
| Autism |
1.3% |
| Blood Pressure Increased |
1.3% |
| Breakthrough Pain |
1.3% |
| Convulsion |
1.3% |
| Diabetes Mellitus |
1.3% |
| Hypertension |
1.3% |
| Hypothyroidism |
1.3% |
|
| Cerebrovascular Accident |
26.7% |
| Myocardial Infarction |
23.3% |
| Off Label Use |
10.4% |
| Completed Suicide |
5.9% |
| Lymphocytic Leukaemia |
5.4% |
| Sudden Death |
5.4% |
| Drug Abuse |
3.5% |
| Somnolence |
2.5% |
| Vomiting |
2.5% |
| Product Substitution Issue |
2.0% |
| Agitation |
1.5% |
| Drug Ineffective |
1.5% |
| Hallucination, Visual |
1.5% |
| Incorrect Route Of Drug Administration |
1.5% |
| Overdose |
1.5% |
| Disorientation |
1.0% |
| Drug Effect Decreased |
1.0% |
| Drug Screen Negative |
1.0% |
| Dyspnoea |
1.0% |
| Fatigue |
1.0% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
30.0% |
| Product Used For Unknown Indication |
12.0% |
| Anxiety |
6.0% |
| Depression |
6.0% |
| Psychomotor Hyperactivity |
6.0% |
| Aggression |
4.0% |
| Asthma |
4.0% |
| Back Pain |
4.0% |
| Neck Pain |
4.0% |
| Sinusitis |
4.0% |
| Autonomic Neuropathy |
2.0% |
| Borderline Mental Impairment |
2.0% |
| Breakthrough Pain |
2.0% |
| Crying |
2.0% |
| Fatigue |
2.0% |
| Fibromyalgia |
2.0% |
| Hypoaesthesia |
2.0% |
| Hypoxic-ischaemic Encephalopathy |
2.0% |
| Learning Disorder |
2.0% |
| Narcolepsy |
2.0% |
|
| Completed Suicide |
15.4% |
| Delusional Perception |
7.7% |
| Incorrect Route Of Drug Administration |
7.7% |
| Suicide Attempt |
7.7% |
| Disorientation |
3.8% |
| Dizziness |
3.8% |
| Dyspnoea |
3.8% |
| Hyperthermia |
3.8% |
| Hypoaesthesia |
3.8% |
| Intentional Drug Misuse |
3.8% |
| Lethargy |
3.8% |
| Loss Of Consciousness |
3.8% |
| Mania |
3.8% |
| Medication Error |
3.8% |
| Pain |
3.8% |
| Peripheral Coldness |
3.8% |
| Petit Mal Epilepsy |
3.8% |
| Priapism |
3.8% |
| Sluggishness |
3.8% |
| Somnolence |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.1% |
| Attention Deficit/hyperactivity Disorder |
10.6% |
| Depression |
6.9% |
| Pain |
5.6% |
| Hypercalcaemia Of Malignancy |
5.0% |
| Anxiety |
4.6% |
| Hepatitis C |
4.6% |
| Hypertension |
4.6% |
| Multiple Sclerosis |
4.3% |
| Insomnia |
3.3% |
| Multiple Myeloma |
3.3% |
| Osteoarthritis |
3.0% |
| Muscle Spasticity |
2.6% |
| Sinus Congestion |
2.6% |
| Cardiac Disorder |
2.3% |
| Neck Pain |
2.3% |
| Osteoporosis Postmenopausal |
2.3% |
| Headache |
2.0% |
| Metastases To Bone |
2.0% |
| Narcolepsy |
2.0% |
|
| Weight Decreased |
25.9% |
| Weight Increased |
8.6% |
| Toxic Encephalopathy |
7.4% |
| Vomiting |
7.4% |
| Product Quality Issue |
6.2% |
| Upper Gastrointestinal Haemorrhage |
6.2% |
| No Adverse Event |
4.9% |
| Vision Blurred |
4.9% |
| Blood Glucose Increased |
2.5% |
| Cerebrovascular Accident |
2.5% |
| Cholecystectomy |
2.5% |
| Device Dislocation |
2.5% |
| Drug Effect Delayed |
2.5% |
| Fall |
2.5% |
| Pain |
2.5% |
| Pancreatitis Acute |
2.5% |
| Therapeutic Response Unexpected With Drug Substitution |
2.5% |
| White Blood Cell Count Increased |
2.5% |
| Wrong Drug Administered |
2.5% |
| Abdominal Pain |
1.2% |
|
| Interacting |
|
| Serotonin Syndrome |
100.0% |
|
